LFMD investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants materially overstated LifeMD's competitive position; (2) defendants were reckless in raising LifeMD's 2025 guidance, considering that they had not properly accounted for rising customer acquisition costs in LifeMD's RexMD segment, as well as for customer acquisition cost ...

Accessibility StatementSkip Navigation SMLR investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Semler Scientific did not disclose a material investigation by the United States Department of Justice into violations of the False Claims Act, while discussing possible violations of the False Claims Act in hypothetical terms; and (2) as a re ...

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to ...

美国司法部还表示，34岁的吴舰是一名居住在纽约的中国公民，目前处于在逃状态，无法立即确定他的律师。 近日，美国司法部表示，吴舰被指控犯有电汇欺诈、证券欺诈和洗钱罪。 每经编辑｜何小桃 曾在小红书晒出2350万美元（约合人民币1.67亿元）年薪的吴舰，正面临美国证券交易委员会和美国司法部的民事刑事双重起诉。 根据吴舰的Linkedin（领英）简介，他在2011年取得了清华大学的工学学士学位，并于2017年从美国康奈尔大学获得了哲学博士学位。 名校毕业的吴舰曾在美国知名做市商Citadel（城堡投资）实习，于2018年4月加入顶尖量化对冲基金Two Sigma，从量化研究员做起，三年时间不到就升任 Two Sigma量化研究部的副总裁，2023年1月，工作不到五年的吴舰被提拔为高级副总裁。 吴舰2023年曾在小红书"悄悄炫富"，并称"不敢发朋友圈，自己心态还是太年轻，想找个没人认识的地方偷偷炫耀下......"。该帖子显示，其2022年的薪资 相较往年出现暴涨，高达2350万美元。 美国证券交易委员会的起诉书称，在2021年11月至2023年8月期间，吴舰秘密操纵了他创建或帮助创建的至少14个投资模型，吴舰向Tw ...

LOS ANGELES, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming November 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Tronox Holdings PLC (“Tronox” or the “Company”) (NYSE: TROX) common stock between February 12, 2025 and July 30, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR TRONOX INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS T ...

诉讼背景 - 针对LifeMD公司投资者的集体诉讼已启动 涵盖2025年5月7日至8月5日期间购买该公司证券的投资者[1] - 诉讼旨在为遭受损失的投资者挽回损失 主要原告申请截止日期为2025年10月27日[2] 指控内容 - 被告在诉讼期间作出 materially false and/or misleading 陈述 未能披露公司竞争地位被实质性夸大[3] - 公司在提高2025年业绩指引时存在 recklessness 未恰当核算RexMD业务部门不断上升的客户获取成本[3] - 公司未充分披露与肥胖治疗药物（包括Wegovy和Zepbound）销售相关的客户获取成本[3] 影响结果 - 被告关于公司业务运营和前景的陈述被指控为 materially false and misleading 且缺乏合理依据[3] - 当真实细节进入市场后 投资者遭受了经济损失[3]

https://zlk.com/pslra-1/c3-ai-inc-lawsuit-submission-form?prid=166636&wire=4 AI investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. NEW YORK, Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in C3.ai, Inc. ("C3.ai" or the "Company") (NYSE: AI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of C3.ai investors who were adversely affected by alleged securities fraud be ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 12, 2025 /PRNewswire/ --Â Levi &Â Korsinsky, LLP notifies investors in Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Altimmune investors who were adversely affected by alleged securities fraud between August 10, 2023 and June 25, 2025. Follow the link below to get more information and be contacted by a member of our team: CONTACT:Levi ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RxSight, Inc. ("RxSight, Inc." or the "Company") (NASDAQ: RXST) of a class action securities lawsuit. SOURCE Levi & Korsinsky, LLP WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RxSight, Inc. investors who were adversely affected by alleged securities fraud between November 7, 2024 and July 8, 2025. Follow the lin ...

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against RxSight, Inc. (NASDAQ: RXST) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in RxSight, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/rxsight-inc-class-action-lawsuit. Investors have until September 22, 2025, to ask the Court to ...